Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis

Min Chen,Xiao Lei Liu,Yu Jie Zhang,Yong Zhan Nie,Kai Chun Wu,Yong Quan Shi
DOI: https://doi.org/10.1111/1751-2980.12938
2020-09-29
Journal of Digestive Diseases
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aim</h3><p>The role of fecal microbiota transplantation (FMT) for severe ulcerative colitis (UC) is unclear. This study aimed to evaluate the short‐term efficacy and safety of FMT by washed preparation for moderate to severe active UC.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>An open‐label, prospective trial was conducted in an inflammatory bowel disease (IBD) tertiary referral center from April 2016 to March 2018. Patients with moderate to severe UC were randomly assigned to undergo FMT three times on day1, day3 and day5 by nasojejunal tube (NJT) or transendoscopic enteral tubing (TET). The primary endpoint was clinical response at week 2 post‐FMT. The secondary endpoints were clinical and endoscopic remission at week 12 post‐FMT, safety and disease progression.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Nine patients were included. 77.8% (7/9) of the patients achieved clinical response at week 2. 55.6% (5/9) and 33.3% (3/9) achieved clinical remission and endoscopic remission at week 12, respectively. 11.1% (1/9) switched to anti‐TNFα therapy and 11.1% (1/9) underwent colectomy. FMT was delivered through NJT in 44.4% (4/9) of the patients, while TET was used in 55.6% (5/9). The clinical outcomes were not significantly different based on the delivery route (p&gt;0.05). Adverse events, which were all mild and self‐limited, were observed in 33.3% (3/9) of the patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>FMT by washed preparation appears to be a safe and effective adjunct therapy for patients with moderate to severe UC in a short‐term follow‐up. The efficacy was not significantly different between the FMT delivery routes (NJT or TET). Further randomized controlled studies are needed to confirm these findings.</p><p>This article is protected by copyright. All rights reserved.</p></section>
gastroenterology & hepatology
What problem does this paper attempt to address?